BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9031774)

  • 1. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma.
    Andreas J; Brühl K; Eissner D
    Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774
    [No Abstract]   [Full Text] [Related]  

  • 2. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer].
    Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM
    Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult carcinoma of the thyroid presenting with orbital metastasis.
    Mansberg R; Son H; Kean AM
    Clin Nucl Med; 2006 Feb; 31(2):109-11. PubMed ID: 16424702
    [No Abstract]   [Full Text] [Related]  

  • 5. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal scarring causing false-positive uptake on I-131 whole-body imaging.
    Schuster DM; Alazraki N
    Clin Nucl Med; 1998 May; 23(5):334. PubMed ID: 9596168
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we read carefully?
    Medvedec M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of differentiated thyroid cancer.
    Pacini F
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
    Kasner DL; Spieth ME; Starkman ME; Zdor-North D
    Clin Nucl Med; 2002 Nov; 27(11):772-80. PubMed ID: 12394123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I-131 accumulation in folliculitis of the scalp.
    Kinuya S; Yokoyama K; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Oct; 21(10):807-8. PubMed ID: 8896935
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine pooling in dilated greater saphenous vein mimicking contamination.
    Varoglu E; Yildirim M; Bayrakdar R; Kantarci AM; Uslu H
    Clin Nucl Med; 2003 Oct; 28(10):866-8. PubMed ID: 14508289
    [No Abstract]   [Full Text] [Related]  

  • 16. An interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapy.
    Ozcan Kara P; Sari O; Gedik GK; Kocak I; Kaya B
    Rev Esp Med Nucl; 2011; 30(1):36-7. PubMed ID: 21211869
    [No Abstract]   [Full Text] [Related]  

  • 17. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.
    Beaulieu S; Djang D; Minoshima S
    J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
    Fatourechi V; Hay ID; Javedan H; Wiseman GA; Mullan BP; Gorman CA
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1521-6. PubMed ID: 11932275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.